TransAlta Corporation Announces Results of the 2026 Annual and Special Meeting of Shareholders and Election of all Directors
April 30, 2026 18:45 ET | Source: TransAlta Corporation CALGARY, Alberta, April…
Doheny Eye Institute Researchers to Share Cutting-Edge Vision Science Across More Than 20 Sessions at the Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting
PASADENA, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Doheny Eye Institute, one…
EssilorLuxottica: EssilorLuxottica 2026 Annual Shareholders Meeting
EssilorLuxottica 2026 Annual Shareholders’ Meeting All resolutions proposed by the Board of…
Cabaletta Bio Announces Multiple Upcoming Presentations, Including Data on Rese-cel without Preconditioning and Rese-cel with Automated Manufacturing, at the ASGCT 2026 Annual Meeting
April 27, 2026 17:00 ET | Source: Cabaletta Bio PHILADELPHIA, April 27,…
ElevateBio to Present Nine Abstracts Showcasing Advancements Across its Gene Editing Platform at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting
April 27, 2026 17:00 ET | Source: ElevateBio – Posters detail large…
Arbor Biotechnologies to Present Expansion of CNS Editing Platform Capabilities at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting
April 27, 2026 17:00 ET | Source: Arbor Biotechnologies Inc - Oral…
Catheter Precision to Attend and Share New Clinical Data at the 47th Annual Heart Rhythm Society Meeting
April 23, 2026 12:00 ET | Source: Catheter Precision, Inc. VIVO System…
Kyverna Presents Registrational Trial Primary Analysis for Miv-cel in Stiff Person Syndrome Demonstrating Statistically Significant, Durable Clinical Benefit Across All Endpoints in an Oral, Late-Breaker Session at AAN Annual Meeting
Single-dose of miv-cel achieved robust and durable improvements in mobility, reversed disability…
Revolution Medicines to Present Updated Phase 1/2 Clinical Data for Daraxonrasib in First Line Metastatic Pancreatic Cancer Across Monotherapy and Combination Cohorts at the 2026 AACR Annual Meeting
REDWOOD CITY, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc.…
Ascentage Pharma to Present Four Promising Preclinical Studies Demonstrating the Potential of Combination Therapies at American Association for Cancer Research (AACR) 2026 Annual Meeting
ROCKVILLE, Md. and SUZHOU, China, April 19, 2026 (GLOBE NEWSWIRE) -- Ascentage…
